Plus Therapeutics | CYTX - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Baxter International USD 577M 373M 2025-12
Cerus USD 33.33M 8.66M 2024-12
Dr.Reddys Laboratories INR 51.37B 629M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Infinity Pharmaceuticals USD 231K 59K 2023-06
Plus Therapeutics 1.37M 30K 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Starpharma Holdings AUD -736K 2.82M 2025-06
Sun Pharmaceuticals INR 107.66B 2.05B 2025-09
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12